Stem's Q2 2024 revenue was $34.0 million, a 63% decrease year-over-year, primarily due to project timeline extensions. The company reported a net loss of $582.3 million, driven by a one-time non-cash impairment of goodwill. Despite the revenue decline, GAAP gross margin improved to 28%, and the company is revising its full year 2024 guidance.
Revenue decreased 63% year-over-year to $34.0 million.
Net loss was $582.3 million, impacted by a one-time non-cash impairment of goodwill.
GAAP gross margin improved to 28%, up from 13% in Q2 2023.
Contracted backlog reached $1.6 billion, up 14% year-over-year.
Stem is updating its full year 2024 guidance due to recent financial results and expected continuation of interconnection and USDA funding delays. The company anticipates generating positive operating cash flow this year and does not foresee the need to raise additional equity.
Visualization of income flow from segment revenue to net income